A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer.

Pinelopi Samara; Margarita Skopeliti; Marinos Tsiatas; Sylvianna Georgaki; Charilaos Gouloumis; Wolfgang Voelter; Meletios A Dimopoulos; Aristotle Bamias; Ourania Tsitsilonis

Related publications

Editorial Material2015

Cytokine treatment in cancer immunotherapy

Michele Ardolino, Joy Hsu, David H Raulet

Article2020

Combination therapy to enhance NK cell anti-tumor responses

Natalie K. Wolf, Chris J. Nicolai, Susanna M. Dang, Gail Synder, Cristina Blaj, Sarah M. McWhirter, Lora K. Picton, K. Christopher García, David H Raulet

Article2024

Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy

Walter Jackson, Yongkang Yang, Shaima Salman, Dominic Dordai, Yajing Lyu, Emmanuel Datan, Daiana Drehmer, Tina Yi-Ting Huang, Yousang Hwang, Gregg L. Friedman

Article2017

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses

Thornton W. Thompson, Alexander B. Kim, P. Jonathan Li, Jiaxi Wang, Benjamin T. Jackson, Kristen Ting Hui Huang, Lily Zhang, David H Raulet

Article2016

Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection

Sarah E. Clark, Holly Filak, Brandon S. Guthrie, Rebecca L. Schmidt, A. M. Jamieson, Patricia Merkel, Vijaya Knight, Caroline Cole, David H Raulet, Laurel Lenz